Scientific Advisory Committee

Part of TIDES: Oligonucleotide and Peptide Research, Technology and Product Development

Registration

We are not accepting online registrations for this event at this time. For more information, please contact IBC Customer Service by email at reg@ibcusa.com or by phone at 800-390-4078 or US +1 941-554-3500.

Download Brochure

Full Conference Details Inside

Event Information

Related Events

AsiaTIDES: Oligonucleotide and Peptide® Research, Technology and Product Development

February 28 - March 01, 2012
Peptide Discovery and Development

May 20-23, 2012
TIDES: Oligonucleotide and Peptide® Research, Technology and Product Development

May 20-23, 2012

Find Another IBC Event

Oligonucleotide Therapeutics Discovery

CSS

Improving Drug-Like Properties to Accelerate Preclinical and Clinical Development

Part of the TIDES Summit

May 20-23, 2012 · Mandalay Bay Resort & Casino · Las Vegas, NV

David Brown, Ph.D., Director of Research, Mirna Therapeutics, Inc.

Elena Feinstein, M.D., Ph.D., Chief Scientific Officer, Quark Pharmaceuticals

Troels Koch, Ph.D., Vice President, Research and CTO, Santaris Pharma A/S, Denmark

Satya Kuchimanchi, Ph.D., Associate Director, RNAi Lead Development, Alnylam Pharmaceuticals, Inc.

Dmitry Samarsky, Ph.D., Executive Vice President, Technology Development, Guangzhou RiboBio Co. Ltd, China